Drug regulators crack down on the manufacture and sale of fake and substandard new coronavirus infection treatment drugs and crimes
Read Time:1 Minute, 15 Second
The State Drug Administration organized the national drug regulatory authorities to further increase the monitoring, mapping, inspection and case investigation of the manufacture and sale of counterfeit and substandard drugs for the treatment of new coronavirus infections, and seized a batch of counterfeit Paxlovid (nematovir tablets/ritonavir tablets combination package) and unapproved imported drugs during the net closing operation. After inspection, some of the seized products did not contain effective drug ingredients or illegally added other drug ingredients. At present, the case is being handled by the public security department in accordance with the law.
This is what the reporter learned from the State Drug Administration. In order to deeply investigate the risks, eliminate hidden dangers, and effectively protect the public’s drug needs and drug safety, for the recent emergence of the market for the illegal sale of new coronavirus infection treatment drug clues of unknown origin, many local drug regulatory departments to take a combination of online monitoring and offline mapping, digging deep into the source of the case, strict investigation of illegal. Under the unified command, the local drug regulatory authorities in conjunction with the local public security departments joint law enforcement, has destroyed some criminal gangs and nests, found suspected of crime, according to the law, transferred to the public security judicial organs. At the same time, the State Drug Administration is in accordance with the law to promote the development and marketing of new coronavirus treatment drugs to serve the overall situation of epidemic prevention and control.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating